Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
- PMID: 36947108
- PMCID: PMC10032659
- DOI: 10.7554/eLife.86002
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Abstract
COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional malaise, and cognitive dysfunction that last for months and impact everyday functioning, is referred to as Long COVID under the general category of post-acute sequelae of SARS-CoV-2 infection (PASC). PASC is highly heterogenous and may be associated with multisystem tissue damage/dysfunction including acute encephalitis, cardiopulmonary syndromes, fibrosis, hepatobiliary damages, gastrointestinal dysregulation, myocardial infarction, neuromuscular syndromes, neuropsychiatric disorders, pulmonary damage, renal failure, stroke, and vascular endothelial dysregulation. A better understanding of the pathophysiologic mechanisms underlying PASC is essential to guide prevention and treatment. This review addresses potential mechanisms and hypotheses that connect SARS-CoV-2 infection to long-term health consequences. Comparisons between PASC and other virus-initiated chronic syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome will be addressed. Aligning symptoms with other chronic syndromes and identifying potentially regulated common underlining pathways may be necessary for understanding the true nature of PASC. The discussed contributors to PASC symptoms include sequelae from acute SARS-CoV-2 injury to one or more organs, persistent reservoirs of the replicating virus or its remnants in several tissues, re-activation of latent pathogens such as Epstein-Barr and herpes viruses in COVID-19 immune-dysregulated tissue environment, SARS-CoV-2 interactions with host microbiome/virome communities, clotting/coagulation dysregulation, dysfunctional brainstem/vagus nerve signaling, dysautonomia or autonomic dysfunction, ongoing activity of primed immune cells, and autoimmunity due to molecular mimicry between pathogen and host proteins. The individualized nature of PASC symptoms suggests that different therapeutic approaches may be required to best manage specific patients.
Keywords: Long COVID; PASC; angiotensin-converting enzyme; epidemiology; global health; immunology; inflammation; pathobiological mechanisms; pathophysiological mechanisms; post-viral syndromes; tissue damage.
Conflict of interest statement
ZS, CG, TC, TH, WR No competing interests declared
Figures
Similar articles
-
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.Front Microbiol. 2021 Jun 23;12:698169. doi: 10.3389/fmicb.2021.698169. eCollection 2021. Front Microbiol. 2021. PMID: 34248921 Free PMC article. Review.
-
Long COVID in pediatrics-epidemiology, diagnosis, and management.Eur J Pediatr. 2024 Apr;183(4):1543-1553. doi: 10.1007/s00431-023-05360-y. Epub 2024 Jan 27. Eur J Pediatr. 2024. PMID: 38279014 Free PMC article. Review.
-
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1. Curr Neurol Neurosci Rep. 2021. PMID: 34181102 Free PMC article. Review.
-
Long Covid.Prog Mol Biol Transl Sci. 2024;202:113-125. doi: 10.1016/bs.pmbts.2023.11.002. Epub 2024 Jan 3. Prog Mol Biol Transl Sci. 2024. PMID: 38237983
-
Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.Geroscience. 2025 Feb;47(1):167-187. doi: 10.1007/s11357-024-01323-9. Epub 2024 Aug 29. Geroscience. 2025. PMID: 39207648 Free PMC article. Review.
Cited by
-
Molecular cross-talk between long COVID-19 and Alzheimer's disease.Geroscience. 2024 Jun;46(3):2885-2899. doi: 10.1007/s11357-024-01096-1. Epub 2024 Feb 23. Geroscience. 2024. PMID: 38393535 Free PMC article. Review.
-
Long-Term Impairment of Working Ability in Subjects under 60 Years of Age Hospitalised for COVID-19 at 2 Years of Follow-Up: A Cross-Sectional Study.Viruses. 2024 Apr 26;16(5):688. doi: 10.3390/v16050688. Viruses. 2024. PMID: 38793570 Free PMC article.
-
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19.medRxiv [Preprint]. 2023 Jul 31:2023.07.27.23293177. doi: 10.1101/2023.07.27.23293177. medRxiv. 2023. PMID: 37577714 Free PMC article. Preprint.
-
A prospective natural history study of post acute sequalae of COVID-19 using digital wearables: Study protocol.Res Sq [Preprint]. 2023 Dec 7:rs.3.rs-3694818. doi: 10.21203/rs.3.rs-3694818/v1. Res Sq. 2023. Update in: JMIR Res Protoc. 2024 Aug 16;13:e57382. doi: 10.2196/57382. PMID: 38105936 Free PMC article. Updated. Preprint.
-
Prevalence, Evolution and Prognostic Factors of PASC in a Cohort of Patients Discharged from a COVID Unit.Biomedicines. 2025 Jun 9;13(6):1414. doi: 10.3390/biomedicines13061414. Biomedicines. 2025. PMID: 40564133 Free PMC article.
References
-
- Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. New England Journal of Medicine. 2020;383:120–128. doi: 10.1056/NEJMoa2015432. - DOI - PMC - PubMed
-
- Aird WC. Phenotypic heterogeneity of the endothelium: II. representative vascular beds. Circulation Research. 2007;100:174–190. doi: 10.1161/01.RES.0000255690.03436.ae. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous